UPDATE : Wednesday, June 19, 2019
상단여백
Regulator OKs immunotherapies developed by multinational pharma companies by Lee Han-soo 2019-03-25 11:28
Otsuka Korea CEO receives presidential citation by Lee Han-soo 2019-03-22 16:52
Setback in search for Alzheimer’s drug: Biogen halts phase-3 aducanumab trials by Kim Yun-mi 2019-03-22 15:50
Eubiologics gets nod to test botulinum toxin in phase-1 study by Lee Hye-seon 2019-03-22 15:28
‘MSD Korea excessively monitors workers, collects client info without consent’ by Jeong Sae-im 2019-03-22 13:49
라인
AbClon, C&R Research sign CRO contract by Lee Han-soo 2019-03-21 17:17
2 drugs for enlarged prostate not different in depression risk by Lee Hye-seon 2019-03-21 16:51
SK Biopharmaceutical’s US partner gets FDA nod for sleepiness treatment by Lee Han-soo 2019-03-21 15:26
LG Chem licenses in PDC line’s anti-cancer vaccine by Lee Han-soo 2019-03-21 11:17
UK regulator OKs P1 trials of Shin Poong’s thrombotic disease treatment by Jeong Sae-im 2019-03-20 16:22
라인
Medytox launches 3rd BTX product by Lee Han-soo 2019-03-20 11:29
Novo Nordisk Korea unveils diabetes drug Fiasp in Korea by Lee Han-soo 2019-03-19 17:37
‘Bladder cancer treatment OncoTICE not out of stock’ by Lee Hye-seon 2019-03-19 14:44
Il-yang, Hanmi achieve robust sales growth in China by Jeong Sae-im 2019-03-19 11:21
Macrogen, Microba to cooperate on microbiome research by Lee Han-soo 2019-03-19 11:14
라인
Daewoong wins right to sell TerahVax’s typhoid fever vaccine by Lee Han-soo 2019-03-19 11:14
Hanmi, Santen sign co-promotion accord for dry eye treatments by Lee Han-soo 2019-03-18 17:46
Dong-A ST to market Suganon in India by Lee Han-soo 2019-03-18 15:03
Merz’ check against Medytox: ‘Xeomin is the only pure toxin’ by Jeong Sae-im 2019-03-18 15:03
Hanmi’s US partner yanks BLA application for Rolontis after FDA demands more data by Lee Han-soo 2019-03-18 14:23
여백
여백
여백
Back to Top